Zacks: Analysts Anticipate Teva Pharmaceutical Industries Ltd (NYSE:TEVA) to Post $0.61 EPS
Wall Street brokerages forecast that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) will post earnings of $0.61 per share for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Teva Pharmaceutical Industries’ earnings, with the lowest EPS estimate coming in at $0.56 and the highest estimate coming in at $0.67. Teva Pharmaceutical Industries reported earnings of $0.53 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 15.1%. The firm is expected to report its next earnings results on Wednesday, February 12th.
On average, analysts expect that Teva Pharmaceutical Industries will report full-year earnings of $2.38 per share for the current year, with EPS estimates ranging from $2.25 to $2.48. For the next ye ...